Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Contribution of the COMT Val158Met variant to symptomatic knee osteoarthritis.

Neogi T, Soni A, Doherty SA, Laslett LL, Maciewicz RA, Hart DJ, Zhang W, Muir KR, Wheeler M, Cooper C, Spector TD, Cicuttini F, Jones G, Nevitt M, Liu Y, Arden NK, Doherty M, Valdes AM.

Ann Rheum Dis. 2014 Jan;73(1):315-7. doi: 10.1136/annrheumdis-2013-203836. Epub 2013 Jul 13. No abstract available.

2.

Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence.

Lohoff FW, Weller AE, Bloch PJ, Nall AH, Ferraro TN, Kampman KM, Pettinati HM, Oslin DW, Dackis CA, O'Brien CP, Berrettini WH.

Neuropsychopharmacology. 2008 Dec;33(13):3078-84. doi: 10.1038/npp.2008.126. Epub 2008 Aug 13.

3.

The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols.

Sak K.

Drug Metab Rev. 2017 Feb;49(1):56-83. doi: 10.1080/03602532.2016.1258075. Epub 2016 Nov 23. Review.

PMID:
27826992
4.

Catechol-O-methyltransferase Val158Met polymorphism: modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease.

Wu H, Dong F, Wang Y, Xiao Q, Yang Q, Zhao J, Quinn TJ, Chen SD, Liu J.

Parkinsonism Relat Disord. 2014 Oct;20(10):1094-6. doi: 10.1016/j.parkreldis.2014.07.011. Epub 2014 Jul 27.

PMID:
25108642
5.

Catechol-O-methyltransferase Val158Met polymorphism and altered COMT gene expression in the prefrontal cortex of suicide brains.

Du L, Merali Z, Poulter MO, Palkovits M, Faludi G, Anisman H.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:178-83. doi: 10.1016/j.pnpbp.2013.12.016. Epub 2014 Jan 2.

PMID:
24389396
6.

Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients.

Lanni C, Garbin G, Lisa A, Biundo F, Ranzenigo A, Sinforiani E, Cuzzoni G, Govoni S, Ranzani GN, Racchi M.

J Alzheimers Dis. 2012;32(4):919-26. doi: 10.3233/JAD-2012-120358.

PMID:
22890094
7.

No association between the Catechol-O-Methyltransferase (COMT) val158met polymorphism and cognitive improvement following cognitive remediation therapy (CRT) in schizophrenia.

Greenwood K, Hung CF, Tropeano M, McGuffin P, Wykes T.

Neurosci Lett. 2011 Jun 1;496(2):65-9. doi: 10.1016/j.neulet.2011.03.075. Epub 2011 Mar 31. Erratum in: Neurosci Lett. 2011 Jul 15;499(1):57.

PMID:
21458532
8.

Catechol-O-methyltransferase (COMT) Val158Met polymorphism and risk of osteoporotic fracture.

Cao Y, Wang D, Liu B, Yao G, Fu Y, Bi Z.

Mol Biol Rep. 2012 Mar;39(3):2975-9. doi: 10.1007/s11033-011-1059-9. Epub 2011 Jun 21.

PMID:
21691708
9.

Contribution of catechol-O-methyltransferase Val158Met polymorphism to endometrial cancer risk in postmenopausal women: a meta-analysis.

Lin G, Zhao J, Wu J, Andreevich O R, Zhang WH, Zhang Y, Yu L.

Genet Mol Res. 2013 Dec 10;12(4):6442-53. doi: 10.4238/2013.December.10.5.

10.

Effect of the COMT val158met polymorphism on white matter connectivity in patients with major depressive disorder.

Seok JH, Choi S, Lim HK, Lee SH, Kim I, Ham BJ.

Neurosci Lett. 2013 Jun 17;545:35-9. doi: 10.1016/j.neulet.2013.04.012. Epub 2013 Apr 22.

PMID:
23618651
11.

[Association analysis between attention-deficit hyperactivity disorder and Val158Met polymorphism of catechol-O-methyltransferase gene].

Zhang XN, Ruan LM, Le YP, Zhang Y.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Aug;20(4):322-4. Chinese.

PMID:
12903043
12.

Polymorphism of catechol-o-methyltransferase and uterine leiomyoma.

Ates O, Demirturk F, Toprak M, Sezer S.

Mol Cell Biochem. 2013 Mar;375(1-2):179-83. doi: 10.1007/s11010-012-1540-3. Epub 2012 Dec 14.

PMID:
23238870
13.

Catechol-O-methyltransferase Val158Met polymorphism and risk of autism spectrum disorders.

Guo T, Wang W, Liu B, Chen H, Yang C.

J Int Med Res. 2013 Jun;41(3):725-34. doi: 10.1177/0300060513479871. Epub 2013 Apr 15.

PMID:
23613504
14.

No association between COMT Val158Met polymorphism and prostate cancer risk: a meta-analysis.

Zou LW, Xu XJ, Liu T, Wang HY, Fan WJ, Wang XH, Zhang ZX, Zhai JX.

Genet Test Mol Biomarkers. 2013 Jan;17(1):78-84. doi: 10.1089/gtmb.2012.0216. Epub 2012 Nov 1.

PMID:
23116175
15.

Catechol O-methyltransferase (COMT) VAL158MET functional polymorphism, dental mercury exposure, and self-reported symptoms and mood.

Heyer NJ, Echeverria D, Martin MD, Farin FM, Woods JS.

J Toxicol Environ Health A. 2009;72(9):599-609. doi: 10.1080/15287390802706405.

16.

Catechol-O-methyltransferase gene val158met polymorphism and depressive symptoms during early childhood.

Sheikh HI, Kryski KR, Smith HJ, Dougherty LR, Klein DN, Bufferd SJ, Singh SM, Hayden EP.

Am J Med Genet B Neuropsychiatr Genet. 2013 Apr;162B(3):245-52. doi: 10.1002/ajmg.b.32141. Epub 2013 Mar 8.

17.

Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder.

Rothe C, Koszycki D, Bradwejn J, King N, Deluca V, Tharmalingam S, Macciardi F, Deckert J, Kennedy JL.

Neuropsychopharmacology. 2006 Oct;31(10):2237-42. Epub 2006 Mar 8.

18.

Association of MMP-1 -1607 1G/2G (rs1799750) polymorphism with primary knee osteoarthritis in the Greek population.

Lepetsos P, Pampanos A, Kanavakis E, Tzetis M, Korres D, Papavassiliou AG, Efstathopoulos N.

J Orthop Res. 2014 Sep;32(9):1155-60. doi: 10.1002/jor.22647. Epub 2014 May 16.

19.

COMT Val158Met modulates the effect of childhood adverse experiences on the risk of alcohol dependence.

Schellekens AF, Franke B, Ellenbroek B, Cools A, de Jong CA, Buitelaar JK, Verkes RJ.

Addict Biol. 2013 Mar;18(2):344-56. doi: 10.1111/j.1369-1600.2012.00438.x. Epub 2012 Apr 17.

PMID:
22509987
20.

Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene.

Martínez-Jauand M, Sitges C, Rodríguez V, Picornell A, Ramon M, Buskila D, Montoya P.

Eur J Pain. 2013 Jan;17(1):16-27. doi: 10.1002/j.1532-2149.2012.00153.x. Epub 2012 Apr 24.

PMID:
22528689

Supplemental Content

Support Center